title: Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study.
abstract: We enrolled children with acute lymphoblastic leukemia (ALL) in a Pediatric Oncology Group (POG) pilot study to monitor erythrocyte (RBC) methotrexate (MTX) and folate (F) levels before and during treatment. The mean value for RBCF at diagnosis was 0.86 +/- 0.46 nmol/ml RBC in the 214 patients who achieved remission and 1.21 +/- 0.74 nmol/ml RBC in the 10 patients who did not (P = 0.020). Folate levels tended to increase during remission induction, but they dropped following an intensive consolidation with methotrexate to levels that were sustained throughout chemotherapy treatment. Methotrexate levels reached mean values of approximately 0.15 nmol/ml RBC at the end of an intensive methotrexate consolidation, then fell to levels that were sustained throughout maintenance therapy. There was a weak correlation between improved event-free survival and higher RBCMTX levels after consolidation, but no correlation was found between improved survival and the level of RBCMTX or RBCF during maintenance therapy. A larger study with more complete data is needed to determine whether RBCMTX or RBCF might be useful in predicting event-free survival in patients with ALL.
authors: Johns Hopkins Oncology Center, Baltimore, Maryland.
authors: M L
authors: ML
authors: Graham
authors: J J
authors: JJ
authors: Shuster
authors: B A
authors: BA
authors: Kamen
authors: D L
authors: DL
authors: Cheo
authors: M P
authors: MP
authors: Harrison
authors: B G
authors: BG
authors: Leventhal
authors: D J
authors: DJ
authors: Pullen
authors: V M
authors: VM
authors: Whitehead
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002648:Child; D016903:Drug Monitoring; D004912:Erythrocytes / Q000737:chemistry / Q000378:metabolism*; D005492:Folic Acid / Q000097:blood*; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage / Q000097:blood*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood* / Q000188:drug therapy / Q000401:mortality; D012074:Remission Induction; D013997:Time Factors
chemical_list: D005492:Folic Acid; D002955:Leucovorin; D008727:Methotrexate